Molecular quality controls sales will strengthen through 2036, anchored by independent controls at a 58.0% share of the leading product segment in 2026. The market is valued at USD 248.2 million in 2026 and is forecast to reach USD 479.2 million by 2036 as molecular testing accreditation requirements widen.